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The overconsumption of sucrose is closely related to sugar-sweetened beverages and 24 
one of the main factors associated with the increase of metabolic diseases, such as type 25 
2 diabetes, obesity, and insulin resistance. So, the addition of alternative sweeteners to 26 
new fruit-based drinks could contribute to minimizing the incidence or severity of these 27 
pathologies. Nevertheless, current knowledge on the influence of these additives on the 28 
bioactive compounds present in these beverages is still carce. Hence, to contribute to 29 
the understanding of this issue, the plasma concentration of phenolic compounds 30 
(anthocyanins and flavanones), after the ingestion of a new maqui-citrus-based 31 
beverage, supplemented with sucrose (natural high calori ), stevia (natural non-caloric), 32 
or sucralose (artificial non-caloric), was evaluated as evidence of their intestinal 33 
absorption and metabolism previous to renal excretion. The beverages were ingested by 34 
volunteers (n=20) and the resulting phenolic metabolites in plasma were analyzed by 35 
UHPLC-ESI-MS/MS. A total of 13 metabolites were detected: caffeic acid sulfate, 36 
caffeic acid glucuronide, 3,4-dihydroxyfenylacetic, 3,4-dihydroxyfenylacetic sulfate. 37 
3,4-dihydroxyfenylacetic acid di-sulfate, 3,4-dihydroxyfenylacetic di-glucuronide, 3,4-38 
dihydroxyfenylacetic glucuronide-sulfate, trans-ferulic acid glucuronide, naringenin 39 
glucuronide, vanillic acid, vanillic acid sulfate, vanillic acid glucuronide-sulfate, and 40 
vanillic acid di-glucuronide, being recorded their maximum concentration after 30-60 41 
minutes. In general, sucralose provided the greatest bsorption value for most of these 42 
metabolites, followed by stevia. Due to this, the pr sent study proposes sucralose and 43 
stevia (non-caloric sweeteners) as valuable alternatives to sucrose (high caloric 44 
sweetener), to avoid the augmented risk of several metabolic disorders. 45 
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Abbreviations: BMI, body mass index; CA, caffeic acid; CAT, catechol; Cy, Cyanidin; 48 
DHPAA, 3,4-dihydroxyphenylacetic acid; DM2, diabetes mellitus 2; Dp, delphinidin; 49 
E, eriodictyol; ESI, electrospray ionization; GA, gallic acid; Glc, glucoside; Glu, 50 
glucuronide; H, hesperetin; HA, hippuric acid; HE, homoeriodictyol; MRM, multiple 51 
reaction monitoring; N, naringenin; TFA, trans-ferulic acid; THBA, 2,4,6-52 
trihydroxybenzaldehid; TIFA, trans-isoferulic acid; VA, vanillic acid; WHO, World 53 
Health Organization. 54 









1. Introduction 56 
Changes in dietary habits, set-up during the last deca es, have been associated 57 
with an increased incidence of obesity and type 2 Diabetes Mellitus (DM2). One factor 58 
critically related to this metabolic disorder is the overconsumption of sucrose, which is 59 
closely linked to sugar-sweetened beverages [1]. 60 
In this scenario, the World Health Organization (WHO), jointly with other 61 
institutions, has called for regulations that could re uce the intake of sugar, including 62 
the regulation of the composition of marketable sweetened beverages. Due to this, the 63 
lookout for alternative sweeteners and the elaboration of healthy beverages has become 64 
a cornerstone to control risk factors associated with obesity and DM2 [2]. 65 
According to this growing awareness, fruit beverages fit the current trend of 66 
increasing the consumption of bioactive compounds that have an array of health 67 
benefits, contributing to prevent the incidence and severity of diverse diseases 68 
associated with sugar consumption [3]. However, the bioavailability of these phenolic 69 
compounds is generally low (up to 10% of the total intake) concerning non-esterified 70 
compounds, although when considering the derivatives formed as a result of the phase 71 
II reactions and the colonic metabolism, bioavailability ranges between 60% and 70%. 72 
Indeed, the variation of the bioavailability values is strongly conditioned by the inter-73 
individual variability in terms of intestinal absorption and metabolism, as well as by the 74 
physicochemical properties of the food/beverage matrices [4]. In this regard, the health 75 
benefits associated to the consumption of these bevrages have raised the incorporation 76 
in diets of natural sources of bioactive phytochemicals, being citrus fruits considered as 77 
a specially valuable ingredient in the development of functional beverages [3,5], as they 78 
are rich in flavanones (e.g. narirutin, eriocitrin, neohesperidin, and hesperidin), as well 79 









Besides citrus fruits, Maqui berry (Aristotelia chilensis (Mol.) Stuntz), has been 81 
also widely used in the development of functional beverages, based on its value as a 82 
source of bioavailable and bioactive compounds, such as anthocyanins, represented by 83 
eight different derivatives of cyanidin and delphinid  [6]. 84 
Based on these antecedents, these two fruits (citrus juices and maqui berry) have 85 
been promoted as interesting ingredients for the development of new functional 86 
beverages [7–9]. However, additional information and  deeper understanding regarding 87 
the influence of alternative sweeteners on the pharmacokinetics of the bioactive 88 
compounds are still needed. 89 
Therefore, the present article is aimed at uncovering the influence of diverse 90 
sweeteners, including sucrose (natural high caloric), stevia (natural non-caloric), and 91 
sucralose (artificial non-caloric), on the plasma concentration of flavanones and 92 
anthocyanins in healthy, overweight, humans, after th  acute intake of (poly)phenol-rich 93 
beverages developed on the base of these fruits. The sweeteners assessed in this work 94 
were selected to compare a classical, natural, and high caloric sweetener (sucrose) and 95 
two non-caloric alternatives (sucralose, an artificial, non-caloric, and widely used 96 
sweetener and stevia, a natural emergent sweetener). The assessment of the 97 
concentration of these phenolic compounds and theirm tabolites in plasma is strongly 98 
motivated by the previous description of the urinary concentration in volunteers, which 99 
demonstrated critical differences between sweeteners [8,9]. Also, the analysis of the 100 
plasma concentration of these compounds will provide valuable information on the 101 
delay of their intestinal absorption after consumption, as well as about the identity of the 102 
circulating metabolites responsible for the biological attributions), which can differ 103 









2. Material and methods 106 
2.1. Chemicals and reagents 107 
Cyanidin (Cy) 3-O-glucoside, delphinidin (Dp) 3-O-glucoside, eriodictyol (E), 108 
homoeriodictyol (HE), naringenin, and hesperetin were purchased from TransMIT 109 
(Geiben, Germany). Narirutin, hesperidin, eriocitrin, caffeic (CA; also known as 3,4-110 
dihydroxycinnamic acid), gallic (GA; also known as 3,4,5-trihydroxybenzoic acid), 3,4-111 
dihydroxyphenylacetic (DHPAA), hippuric (HA), trans-ferulic (TFA; also known as 4-112 
hydroxy-3-methoxycinnamic acid), trans-isoferulic (TIFA; also known as 3-hydroxy-4-113 
methoxycinnamic acid), and vanillic (VA; also known as 4-hydroxy-3-methoxybenzoic 114 
acid) acids, 2,4,6-trihydroxybenzaldehid (THBA), and catechol (CAT; also known as 115 
benzene-1,2-diol) were obtained from Sigma Aldrich (St. Louis, USA). Formic acid and 116 
acetonitrile of analytical grade were obtained from Fisher-Scientific (Loughborough, 117 
UK). All solutions were prepared with ultrapure deionized water from a Milli-Q 118 
Advantage A10 ultrapure water purification system (Millipore, Burlington, MA, USA). 119 
 120 
2.2. Beverages production and characterization on the (poly)phenolic content 121 
Fresh dry organic maqui powder was provided by Maqui New Life S.A. 122 
(Santiago, Chile). Cítricos de Murcia S.L. (Murcia, Spain) and AMC Grupo 123 
Alimentación Fresco y Zumos S.A. (Murcia, Spain) supplied the citrus juices. Sucrose 124 
was obtained from AB Azucarera Iberia S.L. (Madrid, Spain), Stevia from AgriStevia 125 
S.L. (Murcia, Spain), and Sucralose from Zukan (Murcia, Spain). 126 
Maqui-citrus beverages were processed as previously described [8,9]. Briefly, 127 
maqui powder was mixed with citrus juices to obtain the base drink. Then, the three 128 









applying 85 °C during 58 seconds Afterward, the mixtures were bottled and stored at 130 
5 ºC until being consumed by the volunteers. 131 
Maqui-citrus drinks were characterized on their (poly)phenolic composition 132 
following the methodology previously described [7,10]. Beverages were centrifuged at 133 
10500 rpm, during 5 min (Sigma 1-13, B. Braun Biotech International, Osterode, 134 
Germany). The supernatants were filtered through a 0.45 mm PVDF membrane (Millex 135 
HV13, Millipore, Bedford, Mass., USA) and analyzed by RT-HPLC-DAD. The 136 
chromatographic analyses were carried out on a Luna 5 µm C18(2)100 Å column 137 
(250.0 x 4.6 mm), using Security Guard Cartridges PFD 4.0 x 3.0 mm both supplied by 138 
Phenomenex (California, USA), using 5% formic acid in deionized Milli-Q water 139 
(solvent A) and 100% methanol (solvent B), upon thelin ar-gradient (time, %B) 140 
(0, 15%); (20, 30%); (30, 40%); (35, 60%); (40, 90%); (44, 90%); (45, 15%), and (50, 141 
15%), using an Agilent Technologies 1220 Infinity Liquid Chromatograph, equipped 142 
with an auto-injector (G1313, Agilent Technologies) and a Diode Array Detector (1260, 143 
Agilent Technologies, California, USA). Chromatograms were recorded and processed 144 
on an Agilent ChemStation for LC 3D systems. The volume of injection and flow rate 145 
were 10 µL and 0.9 mL/min, respectively. The quantification of flavanones and 146 
anthocyanins was done on UV chromatograms recorded at 280 nm as hesperidin and 147 
520 nm as cyanidin 3-O-glucoside, respectively, and expressed as mg per 100 mL of 148 
juice (mg/100 mL). 149 
 150 
2.3. Experimental design 151 
A double-blind, randomized, cross-over clinical study has been conducted in 152 
overweight individuals (n=20), by the Catholic University of Murcia (Murcia, Spain). 153 









Studies (CEIC) of University Hospital ‘Morales Mesegu r’ (Murcia) and registered at 155 
ClinicalTrials.gov (NCT04016337). The volunteers provided written consent to 156 
participate in this study. The criteria for volunteers’ selection to participate in the study 157 
were to be in good health, overweight (body mass index (BMI) between 24.9 and 158 
29.9 kg/m2 following WHO criteria), aged 40-60 years, non-smokers, non-affected by 159 
dyslipidemia, and normotensive, with no chronic illnesses and no taking any 160 
medication. After an initial phase of 3 days of wash-out with a (poly)phenols free and 161 
added sugar-free diet, 330 mL of the test drinks (stevia, sucralose, or sucrose added 162 
sweetener) were administered on fasting conditions. Plasma samples were collected 163 
before the beverage ingestion (0 min point), as well as in the following times: 30, 60, 164 
and 210 min. After 15 days, the process was repeated, for each volunteer ingesting 165 
another drink developed with remaining sweeteners until all types of drink were 166 
consumed by all the volunteers (3 rounds). Plasma samples collected were stored at -167 
80°C until analyses that were performed once each period was finished and in the same 168 
batch to minimize analytical variations. 169 
 170 
2.4. Plasma samples collection, processing, and analysis by UHPLC-ESI-MS/MS 171 
The plasma extraction procedure was applied according to the methodology 172 
previously described [8,9]. Briefly, plasma samples were defrosted and diluted in 173 
acetonitrile/formic acid (98:2, v/v) 1:2,5 (v/v), vortex for 1 min, sonicated for 10 min, 174 
and centrifuged at 15000 g for 10 min, at 5 °C (Sigma 1-16, B. Braun Biotech 175 
International, Osterode, Germany). Afterward, supernatants were concentrated in a 176 
speed vacuum concentrator and reconstituted in 200 µL methanol/Milli-Q-water 0.2% 177 









min, at 5°C (Sigma 1-16, B. Braun Biotech International, Osterod , Germany), and 179 
stored at -20°C until analysis by UHPLC-ESI-MS/MS. 180 
The identification and quantification of phenolic metabolites was performed by 181 
applying the methodology previously reported, with optimized injected volume, flow 182 
rate, and MS parameters, by comparison with freshly prepared standards curves of the 183 
different phenolics [8,9,11]. The analysis of the samples on the profile and 184 
concentration of phenolic metabolites was carried out on a chromatographic column 185 
Ascentis Express F5 (50 x 2.1 mm; 2.7 µm pore size) (Sigma, Osterode, Germany). The 186 
solvents used for the chromatographic separation were d ionized Milli-Q water/formic 187 
acid (99.9:0.1, v/v) (solvent A) and acetonitrile/formic acid (99.9:0.1, v/v) (solvent B), 188 
upon the linear-gradient (time, %B) (0, 10%); (1, 10%); (10, 60%); (11, 80%); (13, 189 
80%); (13.01, 10%), and (14.50, 10%); using an UHPLC system coupled with a triple 190 
quadrupole tandem mass spectrometer, model 6460 (Agilent Technologies, Waldbronn, 191 
Germany), operated in multiple reaction monitoring (MRM) and negative/positive 192 
electrospray ionization (ESI) modes. The volume injcted and flow rate were 10 µL and 193 
0.2 mL/min, respectively. The MS parameters, at the optimized conditions, were gas 194 
temperature 325 ºC; gas flow 10 L/min; nebulizer 40 psi; sheath gas heater 275 ºC; 195 
sheath gas flow 12; capillary voltage 4000–5000 V; Vcharging 1000–2000. Data 196 
acquisition and processing were performed by using MassHunter software version 197 
B.08.00 (Agilent Technologies, Walbronn, Germany) (Table 3). Regarding the 198 
quantification of the diverse compounds identified, values of area providing signal to 199 
noise ratio lower than 1/3, established as the consensus criteria for the limit of detection 200 
(LOD), were considered and in consequence values lower than LOD were neither 201 











2.5. Statistical analysis 205 
Quantitative data are presented as mean ± SD of 20 volunteers. Specific 206 
differences were examined by a Repeated Measure (RM) Multivariate analysis of 207 
variance (ANOVA) as the statistical analysis of election for a number of dependent 208 
variables higher than 2, measured as correlated, which is used when measuring the 209 
effect of an intervention (e.g., a dietary intervention) at different time points. This 210 
statistical model allows testing the main effects within and between the subjects, 211 
interaction effects between factors, and covariate eff cts, as well as the effects of 212 
interactions between covariates and between subject factors. The data were processed 213 
using the SPSS 21.0 software package (SPSS Inc., Chi ago, Ill., U.S.A.) and the level of 214 
significance was set-up at p<0.05. 215 
 216 
3. Results and discussion 217 
3.1. Flavanone and anthocyanin content of beverages 218 
The quantitative profile of the juices regarding the phenolic compounds was set 219 
up, to establish the flavanones and anthocyanins pre ent in the maqui-citrus beverages 220 
developed using three different sweeteners (stevia, sucralose, and sucrose) and thus, 221 
susceptible to be absorbed in the intestine after th i dietary ingestion. In this regard, it 222 
was observed the presence of the four following flavanones: hesperidin (hesperetin 7-O-223 
rutinoside) that presented the highest concentration (4.87 mg/100 mL, on average), 224 
followed by narirutin (naringenin 7-O-rutinoside; 1.31 mg/100 mL, on average), 225 
eriocitrin (eriodictyol 7-O-rutinoside, 0.32 mg/100 mL, on average), and O-triglycosyl-226 
naringenin with the lowest concentrations (0.14 mg/100 mL, on average). On the other 227 









predominant (3.49 mg/100 mL, on average), followed by Dp 3-O-sam-5-O-glc 229 
(3.15 mg/100 mL, on average), Dp 3-O-glc (2.93 mg/100 mL, on average), Cy 3-O-230 
sam-5-O-glc and Cy 3,5-O-di-glc (1.48 mg/100 mL, on average), Dp 3-O-sam 231 
(1.10 mg/100 mL, on average), Cy 3-O-glc (0.55 mg/100 mL, on average), and Cy 3-O-232 
sam (0.40 mg/100 mL, on average). No statistically significant differences (p>0.05) 233 
were observed between the flavanone and anthocyanin co tents of the different maqui-234 
citrus drinks when considering individual or total fl vanones (Tables 1 and 2). 235 
 236 
3.2. Qualitative analysis of plasma metabolites of flavanones and anthocyanins of the 237 
maqui-citrus beverage 238 
To profile the diversity of citrus flavanones and maqui-berry anthocyanins 239 
absorbed at the intestinal level and subsequently present in plasma, samples were 240 
collected before and after the ingestion of 330 mL of the diverse beverages at different 241 
times, and processed to identify possible differences between the three beverages (with 242 
stevia, sucralose, or sucrose added). Based on previous researches [8,9], metabolites 243 
already described in urine after the ingestion of similar juices were looked for. Upon 244 
this strategy, 30 phenolic metabolites derived from flavanones and anthocyanins, were 245 
detected in plasma (Table 3). More specifically, the compounds identified in plasma 246 
were eriodictyol (E), eriodictyol glucuronide (E glu), eriodictyol sulfate (E sulfate), 247 
homoeriodictyol glucuronide (HE glu), homoeriodictyol glucuronide-sulfate (HE glu-248 
sulfate), naringenin (N), O-triglycosyl-naringenin and naringenin glucuronide (N glu), 249 
regarding flavanones. In addition, it was also identifi d the presence of caffeic acid 250 
glucuronide (CA glu), caffeic acid sulfate (CA sulfate), caffeic acid glucuronide-sulfate 251 
(CA glu-sulfate), 3,4-dihydroxyphenylacetic acid (DHPAA), 3,4-dihydroxyphenylacetic 252 









(DHPAA di-glu), 3,4-dihydroxyphenylacetic acid sulfate (DHPAA sulfate), 3,4-254 
dihydroxyphenylacetic acid glucuronide-sulfate (DHPAA glu-sulfate), 3,4-255 
dihydroxyphenylacetic acid di-sulfate (DHPAA di-sulfate), hippuric acid (HA), 256 
hippuric acid sulfate (HA sulfate), hippuric acid glucuronide-sulfate (HA glu-sulfate), 257 
trans-ferulic acid (TFA), trans-ferulic acid glucuronide (TFA glu), trans-ferulic acid di-258 
sulfate (TFA di-sulfate), 2,4,6-trihydroxybenzaldehide (THBA), 2,4,6-259 
trihydroxybenzaldehide sulfate (THBA sulfate), trans-isoferulic acid (TIFA), vanillic 260 
acid (VA), vanillic acid di-glucuronide (VA di-glu), vanillic acid sulfate (VA sulfate) 261 
and vanillic acid glucuronide-sulfate (VA glu-sulfate), concerning anthocyanins. These 262 
phenolic compounds were tentatively identified according to their retention time, 263 
molecular masses, and fragmentation pattern according to the information available in 264 
the literature [11]. 265 
Although hesperidin (hesperetin 7-rutinoside) was the most abundant flavanone in 266 
the beverages, accounting for 73.3% of total flavanones, neither this flavanone nor its 267 
phase II derivatives (H glu, H sulfate, H glu-sulfate, H di-glu and H di-sulfate) were 268 
observed in plasma in concentrations higher than the limit of detection of the method. 269 
Also, none of the precursor anthocyanins (Dp and Cy agl cones) were found in the 270 
plasma samples analyzed. The lack of a proper identification of these anthocyanins in 271 
plasma could be attributed to their degradation during the gastrointestinal digestion 272 
process, as well as due to their low absorption rate at the intestinal level, especially 273 
because of the intestinal absorption mechanisms of anthocyanin glycosides are still 274 
speculative. Moreover, in some extent the fraction of these compounds absorbed at 275 
intestinal level could suffer the metabolism of theepithelial cells and hepatocytes giving 276 
rise to phase II derivatives [12]. In this aspect, it has been recently demonstrated that the 277 









metabolic traits of the volunteers and the inter-individual variation [13]. So that, most 279 
metabolites detected (E, E glu, E sulfate, HE glu, HE glu-sulfate, N, N glc, CA glu-280 
sulfate, DHPAA glu, HA sulfate, HA glu-sulfate, TFA, TFA di-sulfate, THBA, THBA 281 
sulfate and TIFA) were found in a reduced number of v lunteers in a quantifiable 282 
amount, turning them into non-representative, and reinforcing the relevance of the 283 
biological features inherent to each volunteer for the final bioavailability of 284 
(poly)phenols. Moreover, the dispersion detected in the quantitative profile of plasma 285 
metabolites, enclosed to the inter-individual variation, would make difficult to find 286 
significant differences between beverages. 287 
On the other hand, N glu, CA glu, CA sulfate, DHPAA, DHPAA di-glu, DHPAA 288 
sulfate, DHPAA glu-sulfate, DHPAA di-sulfate, HA, TFA glu, VA, VA di-glu, VA 289 
sulfate, and VA glu-sulfate were identified and quantified in plasma of all volunteers. 290 
However, HA was not considered because of its high background levels, probably 291 
originated from other dietary and endogenous sources, making the determination of the 292 
amounts coming from the metabolism of anthocyanins d fficult [14]. 293 
 294 
3.3. Quantitative profile of flavanone and anthocyanin metabolites in plasma 295 
The quantification of circulating metabolites was developed on basal plasma 296 
(0 minutes), as well as on plasma at 30, 60, and 210 minutes. The kinetic for the above-297 
referred metabolites exhibited the highest concentration at 30-60 min in plasma, after 298 
the intake of the beverages, according to previous studies [15], suggesting that 299 
sweeteners do not change the absorption kinetic of flavonoids. For this reason, all 300 
concentrations described are referred to as that time-points (Fig. 1). 301 
The content of N glu in plasma was 0.10 µg/mL, for th se volunteers that ingested 302 









sucralose and sucrose, which displayed concentrations ~25% lower, on average, in 304 
comparison with beverages done using sucralose (Fig. 1). Despite these differences 305 
between sweeteners, the application of the RM ANOVA allowed identifying significant 306 
augments regarding the concentration of N glu at min 30 (p<0.05) for juices developed 307 
using stevia as sweetener. 308 
The amount of whole phase II derivatives of CA recoded was 0.37 ng/mL after 309 
the intake of sucralose-sweetened beverages, being a 29% higher, on average, than the 310 
provided after the intake of beverages prepared using stevia and sucrose as sweeteners. 311 
When analyzing the effect of the sweetener regarding the individual compounds, for CA 312 
glu and CA sulfate, the highest values corresponded to juices developed using sucralose 313 
as sweetener, which gave rise to plasma concentrations of 0.22 and 0.07 ng/mL, 314 
respectively. These concentrations were ~36% higher than those reached when using 315 
stevia and sucrose. (Fig. 1). Summarizing the effect of consuming the juices under 316 
evaluation, the only phase II derivative of CA that increased significantly its 317 
concentration in peripheral blood plasma 30 and 60 min after the dietary intervention, 318 
according with the RM ANOVA was CA glu (p<0.05 and p<0.01, respectively for 319 
stevia and both time points significant at p<0.05 for sucrose and sucralose). 320 
Moreover, sucrose was the sweetener that provided the highest plasma 321 
concentration for the sum of DHPAA and their phase II metabolites (2.44 ng/mL), 322 
which was ~36% higher than the reached when using sucralose and stevia. For DHPAA 323 
di-glu, DHPAA glu-sulfate and DHPAA di-sulfate, the highest value corresponded to 324 
the juices developed with added stevia (0.58; 0.19 and 0.29 ng/mL, respectively). 325 
Nevertheless, for DHPAA sulfate, the beverages elaborated with sucrose were the ones 326 
that provided the highest concentration in plasma, 1.42 ng/mL. The intake of sucralose 327 









DHPAA, 0.33 ng/mL. In this case, when comparing thesweetened beverage which 329 
provided the highest bioavailability for each compound against the remaining ones, the 330 
intestinal absorption rates were ~34% lower, for DHPAA and their phase II metabolites 331 
considered individually (Fig. 1). The only significant increase of the basal plasma 332 
concentration was retrieved for DHPAA di-sulfate at 30 and 60 min after the ingestion 333 
of juices elaborated using sucrose and sucralose as weeteners (p<0.05). 334 
Regarding TFA glu, stevia-sweetened juices provided the highest plasma 335 
concentration (0.81 ng/mL), which resulted in a 75% higher, on average, than the 336 
obtained after the ingestion of sucrose- and stevia-sweetened beverages. 337 
The sum of the plasma concentration of VA and its phase II derivatives provided 338 
values of 6.13 ng/mL, in volunteers ingesting sucralose-sweetened juices, while the 339 
beverages developed based on stevia and sucrose gave rise to plasma concentrations 340 
57% lower values, on average. When considering individual metabolites, for VA di-glu, 341 
VA sulfate, and VA glu-sulfate, the highest value corresponded to sucralose-sweetened 342 
juices, with the average plasma concentration values 1.93, 1.45 and 2.38 ng/mL, 343 
respectively. However, for VA, stevia-based drinks displayed the highest concentrations 344 
(0.81 ng/mL) (Fig. 1). Although, the dispersion of the values recorded as a result of 345 
inter-individual variability did not allow retrieving significant differences between 346 
sweeteners when applying the one-way ANOVA and Duncan’s multiple range tests 347 
[16], when analyzing the increase caused by the separate sweeteners using MR 348 
ANOVA, it was observed that non-esterified VA and total VA experienced a significant 349 
augment after 60 min (p<0.05) for stevia-sweetened beverages. 350 
As overall, results, described on the intestinal absorption of flavanones and 351 
anthocyanins after the intake of the developed beverages, indicated that stevia and 352 









achieved for most flavanone and anthocyanin metabolites (N glu, DHPAA di-glu, 354 
DHPAA glu-sulfate, DHPAA di-sulfate, TFA glu and VA, for stevia; CA glu, CA 355 
sulfate, DHPAA, VA di-glu, VA sulfate and VA glu-sulfate, for sucralose), while 356 
sucrose only provided significantly higher concentrations of DHPAA sulfate. These 357 
differences could be attributable to the central role of intestinal sugar transporters in the 358 
absorption of flavonoids, as well as to the competence events that could be established 359 
between the separate sweeteners used and the phenolic compounds found [12]. In this 360 
regard, the central role of the sugar transporters in the absorption of phenolic 361 
compounds has been established on the base of characterizing the influence of the 362 
attached sugar in esterified phenolics that also conditi n strongly their solubility in the 363 
intestinal mucus as part of the mechanism of polyphenols absorption, as described for 364 
catechins, flavanones or phenolic acids [17]. However, the gap of knowledge on the 365 
effects of other components of foods, such as sweeten rs present in manufactured 366 
products, on the bioavailability of polyphenols are underexplored, being required 367 
additional human studies to set-up the general principles affecting absorption i vivo. 368 
Thus, these results suggest that both stevia and sucralose were better than sucrose 369 
in terms of intestinal absorption of citrus and maqui phenolics. In this aspect, several 370 
studies, describing the effects on human health and metabolic diseases of stevia and 371 
sucralose, have reported contradictory results as extensively reviewed by Daher et al. 372 
[18]. In this case, the majority of these interventio al studies are focused on non-373 
nutritional sweeteners isolated, the reason why the interaction of sweeteners with diet 374 
remains underexplored [18]. 375 
The interest of establishing the pharmacokinetic features of (poly)phenols in 376 
functional beverages is supported by their widely recognized biological benefits in 377 









studies have suggested the cardioprotective activity of hesperidin and its aglycone, 379 
hesperetin (H) [4,19,20]. Besides, a study carried out on adults affected by metabolic 380 
syndrome revealed that the dietary ingestion of 500mg hesperidin per day, for three 381 
weeks, improves the endothelial function and reduces th  level of inflammatory markers 382 
[21]. On the other hand, anthocyanins are featured by valuable biological properties, 383 
including high radical scavenging activity, and thecapacity to protect humans against 384 
risk factors for cardiovascular diseases and to inhib t adipogenesis, inflammation, and 385 
diabetes symptoms [6,22]. Also, recent meta-analyses of prospective cohort studies 386 
have evidenced that the dietary intake of anthocyanins reduces the risk of DM2 and 387 
cardiovascular disease, thus providing vascular benefits [23]. 388 
 389 
4. Conclusions 390 
The results obtained in the present work shed light on the absorption ratio for 391 
berry anthocyanins and citrus flavanones, as well as a variety of phase II derivatives, 392 
resulting from the gastrointestinal process on these phenolic compounds. This is of 393 
special relevance because of the protective attribuions of these compounds against 394 
cardiovascular diseases, and to decrease the severity of inflammatory processes and 395 
diabetes symptoms. The results obtained suggested that the greatest bioavailability for 396 
most of these metabolites was provided by stevia and sucralose, while, sucrose showed 397 
higher bioavailability only in 1 out of the 13 metabolites analyzed. So, considering the 398 
significantly different bioavailability achieved when ingesting beverages developed 399 
using the three sweeteners, this study proposes sucralose and stevia (non-caloric 400 
sweeteners) as valuable alternatives to sucrose (high caloric sweetener), which 401 
consumption has been associated to an augmented risk of DM2, obesity, and other 402 








acute intervention study, the development of an intervention assay addressed to set-up 404 
the effect of the chronic ingestion of the best juices according to our results could be 405 
interesting to understand more about the effects on human health of the two alternatives. 406 
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FIGURE CAPTIONS 484 
Fig. 1. Content (mean ± SD, n=20) of single flavonoid metabolites in basal peripheral 485 
blood plasma and plasma obtained, from healthy overweight volunteers, 30, 60, and 210 486 
minutes after ingesting 330 mL of maqui-citrus beverag s developed using stevia (▲), 487 
sucralose (●), and sucrose (■), as sweeteners. 488 










Table 1. Flavanone composition of the maqui-citrus juices. 
Beverages 
Flavanones Z (mg/100mL) 
O-triglycosyl-N E 7-O-rutinoside N 7-O-rutinoside H 7-O-rutinoside TOTAL 
Stevia 0.15 ± 0.02 0.32 ± 0.04 1.30 ± 0.01 4.87 ± 0.01 6.64 ± 
0.2 
Sucralose 0.14 ± 0.02 0.32 ± 0.01 1.31 ± 0.01 4.86 ± 0.01 6.63 ± 
0.1 
Sucrose 0.14 ± 0.01 0.31 ± 0.03 1.31 ± 0.01 4.88 ± 0.01
6.64 ± 
0.1 
P-value >0.05 N.s. >0.05 N.s. >0.05 N.s. >0.05 N.s. >0.05 N.s. 
Z N, naringenin; E, eriodictyol; H, hesperetin. 









Table 2. Anthocyanins composition of the maqui-citrus juices. 
Beverages 
Anthocyanins Z (mg/100mL) 




Dp 3-O-sam Dp 3-O-glc Cy 3-O-sam Cy 3-O-glc TOTAL 
Stevia 3.06 ± 0.12 3.59 ± 0.02 1.54 ± 0.02 1.09 ± 0.01 2.87 ± 0.02 0.40 ± 0.01 0.54 ± 0.01 13.1 ± 0.2 
Sucralose 3.19 ± 0.05 3.51 ± 0.01 1.51 ± 0.01 1.11 ± 0.01 3.02 ± 0.01 0.41 ± 0.01 0.57 ± 0.01 13.3 ± 0.1 
Sucrose 3.19 ± 0.01 3.36 ± 0.09 1.38 ± 0.01 1.09 ± .01 2.90 ± 0.01 0.40 ± 0.01 0.55 ± 0.01 12.9 ± 0.2 
P-value >0.05 N.s. >0.05 N.s. >0.05 N.s. >0.05 N.s. >0.05 N.s. >0.05 N.s. >0.05 N.s. >0.05 N.s. 
Z Cy, cyanidin; Dp, delphinidin; Glc, glucoside; Sam, sambubioside. 









Table 3. Qualitative analysis of anthocyanin and flavanone metabolites in plasma after the ingestion of 
maqui-citrus juices determined by UHLC-ESI-QqQ-MS/M operated in multiple reaction monitoring, 
















Cyanidin (Cy) 8.81 (<LOD) 287.0 137.0 100 20 Positive 
Cy 3-O-glucoside <LOD 449.0 287.0 100 20 Positive 
Cy 3,5-O-di-glucoside <LOD 743.0 287.0 100 20 Positive 
Cy 3-O-sambubioside <LOD 581.0 287.0 100 20 Positive 
Cy 3-O-sambubioside-5-O-
glucoside 
<LOD 611.0 287.0 100 20 Positive 
       
Delphinidin metabolites 
Delphinidin (Dp) 5.18 (<LOD) 303.0 229.0/257.0 100 20 Positive 
Dp 3-O-glucoside <LOD 465.0 303.0 100 20 Positive 
Dp 3,5-O-di-glucoside <LOD 627.0 303.0 100 20 Positive 
Dp 3-O-sambubioside <LOD 597.0 303.0 100 20 Positive 
Dp 3-O-sambubioside-5-O-
glucoside 
<LOD 759.0 303.0 100 20 Positive 
       
Eriodictyol metabolites        
Eriodictyol (E) 6.49 287.0 151.0 70 10 Negative 
Eriocitrin <LOD 449.0 287.0 70 10 Negative 
E glucuronide 4.87 463.0 287.0 70 10 Negative 
E di-glucuronide <LOD 639.0 287.0 70 10 Negative 
E sulfate 5.53 367.0 287.0 70 10 Negative 
E di-sulfate <LOD 447.0 287.0 70 10 Negative 
E glucuronide-sulfate <LOD 543.0 287.0 70 10 Negative 
       
Hesperetin metabolites       
Hesperetin (H) 7.30 (<LOD) 302.0 151.0 70 20 Negative 
Hesperidin <LOD 609.0 302.0 70 20 Negative 
H glucuronide <LOD 478.0 302.0 70 20 Negative 
H di-glucuronide <LOD 664.0 302.0 70 20 Negative 
H sulfate <LOD 382.0 302.0 70 20 Negative 
H di-sulfate <LOD 462.0 302.0 70 20 Negative 
H glucuronide-sulfate <LOD 558.0 302.0 70 20 Negative 
       
Homoeriodictyol metabolites       
Homoeriodictyol (HE) 7.30 (<LOD) 301.0 151.0 110 15 Negative 
HE glucuronide 5.50 477.0 301.0 110 15 Negative 
HE di-glucuronide <LOD 653.0 301.0 110 15 Negative 
HE sulfate <LOD 381.0 301.0 110 15 Negative 
HE di-sulfate <LOD 461.0 301.0 110 15 Negative 
HE glucuronide-sulfate 4.67 557.0 301.0 110 15 Negative 
       
Naringenin metabolites        
Naringenin (N) 7.26 271.0 119.0 130 20 Negative 
O-triglycosyl-N 4.63 433.0 271.0 130 20 Negative 
Narirutin <LOD 579.0 271.0 130 20 Negative 
N glucuronide 5.07 433.0 271.0 130 20 Negative 
N di-glucuronide <LOD 623.0 271.0 130 20 Negative 
N sulfate <LOD 351.0 271.0 130 20 Negative 
N di-sulfate <LOD 431.0 271.0 130 20 Negative 
N glucuronide-sulfate <LOD 527.0 271.0 130 20 Negative 
<LOD, lower than the limit of detection. 









Table 3. Qualitative analysis of anthocyanin and flavanone metabolites in plasma after the ingestion of 
maqui-citrus juices determined by UHLC-ESI-QqQ-MS/M operated in multiple reaction monitoring, 
in negative and positive ionization modes, respectiv ly (Cont.). 
Caffeic acid metabolites 
Caffeic acid (CA) 3.25 (<LOD) 179.1 135.0 70 15 Negative 
CA glucuronide 2.40 355.1 179.1 70 15 Negative 
CA di-glucuronide 1.67 531.1 179.1 70 15 Negative 
CA sulfate 2.99 259.1 179.1 70 15 Negative 
CA glucuronide-sulfate 1.95 435.1 179.1 70 15 Negative 
CA di-Sulfate <LOD 339.1 179.1 70 15 Negative 
       
Catechol metabolites 
Catechol (CAT) 5.04 (<LOD) 109.0 67.0 80 6 Negative 
CAT glucuronide <LOD 286.0 109.0 80 6 Negative 
CAT di glucuronide 2.83 (<LOD) 461.0 109.0 80 6 Negative 
CAT sulfate 1.59 (<LOD) 189.0 109.0 80 6 Negative 
CAT glucuronide-sulfate 1.38 (<LOD) 365.0 109.0 80 6 Negative 
CAT di-sulfate <LOD 269.0 109.0 80 6 Negative 
       
3,4-Dihydroxyphenylacetic acid metabolites 
3,4-Dihydroxyphenylacetic acid 
(DHPAA) 
1.80 166.8 123.2 70 5 Negative 
DHPAA glucuronide 1.58 342.8 166.8 70 5 Negative 
DHPAA di-glucuronide 1.04 518.8 166.8 70 5 Negative 
DHPAA sulfate 1.14 246.8 166.8 70 5 Negative 
DHPAA glucuronide-sulfate 0.74 422.8 166.8 70 5 Negative 
DHPAA di-sulfate 1.07 326.8 166.8 70 5 Negative 
       
Hippuric acid metabolites 
Hippuric acid (HA) 2.55 178.0 134.4 80 5 Negative 
HA glucuronide 1.70 (<LOD) 354.0 178.0 80 5 Negative 
HA di-glucuronide 0.59 (<LOD) 530.0 178.0 80 5 Negative 
HA sulfate 1.78 258.0 178.0 80 5 Negative 
HA glucuronide-sulfate 1.50 434.0 178.0 80 5 Negative 
HA di-sulfate <LOD 338.0 178.0 80 5 Negative 
       
Gallic acid metabolites 
Gallic acid (GA) 0.71 (<LOD) 169.0 125.0 70 10 Negative 
GA glucuronide <LOD 345.0 169.0 70 10 Negative 
GA di-glucuronide <LOD 521.0 169.0 70 10 Negative 
GA sulfate <LOD 249.0 169.0 70 10 Negative 
GA glucuronide-sulfate <LOD 425.0 169.0 70 10 Negative 
GA di-sulfate <LOD 329.0 169.0 70 10 Negative 
       
Trans-ferulic acid metabolites 
Trans-ferulic acid (TFA) 4.46 192.8 133.8 20 5 Negative 
TFA glucuronide 4.25 368.8 192.8 20 5 Negative 
TFA di-glucuronide 1.74 (<LOD) 544.8 192.8 20 5 Negative 
TFA sulfate 3.56 (<LOD) 272.8 192.8 20 5 Negative 
TFA glucuronide-sulfate <LOD 448.8 192.8 20 5 Negative 
TFA di-sulfate 1.32 352.8 192.8 20 5 Negative 
<LOD, lower than the limit of detection. 









Table 3. Qualitative analysis of anthocyanin and flavanone metabolites in plasma after the ingestion of 
maqui-citrus juices determined by UHLC-ESI-QqQ-MS/M operated in multiple reaction monitoring, 




5.10 153.1 106.8 90 18 Negative 
THBA glucuronide 5.08 (<LOD) 329.1 153.1 90 18 Negative 
THBA di-glucuronide <LOD 505.1 153.1 90 18 Negative 
THBA sulfate 1.46 233.1 153.1 90 18 Negative 
THBA glucuronide-sulfate <LOD 409.1 153.1 90 18 Negative 
THBA di-sulfate <LOD 313.1 153.1 90 18 Negative 
       
Trans-isoferulic acid metabolites 
Trans-isoferulic acid (TIFA) 1.46 193.7 134.7 70 5 Negative 
TIFA glucuronide <LOD 366.7 193.7 70 5 Negative 
TIFA di-glucuronide <LOD 545.7 193.7 70 5 Negative 
TIFA sulfate 1.45 (<LOD) 273.7 193.7 70 5 Negative 
TIFA glucuronide-sulfate <LOD 449.7 193.7 70 5 Negative 
TIFA di-sulfate <LOD 353.7 193.7 70 5 Negative 
       
Vanillic acid metabolites 
Vanillic acid (VA) 3.18 167.0 151.8 100 15 Negative 
VA glucuronide 1.57 (<LOD) 343.0 167.0 100 15 Negative 
VA di-glucuronide 1.01 519.0 167.0 100 15 Negative 
VA sulfate 1.14 247.0 167.0 100 15 Negative 
VA glucuronide-sulfate 0.93 423.0 167.0 100 15 Negative 
VA di-sulfate 1.13 (<LOD) 327.0 167.0 100 15 Negative 
<LOD, lower than the limit of detection. 























NUTRITION, METABOLISM, AND CARDIOVASCULAR DISEASES 
 
Sweetener influences plasma concentration of flavonoids in 





- Plasma concentration of bioavailable anthocyanins and flavanones was determined 
- Sweetener were assessed on their capacity to influence the bioavailability of 
anthocyanins and flavanones 
- The greatest bioavailability for these metabolites was provided by sucralose and 
stevia 
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